Keywords: sepracor, losses, grow, market, keeps, faith, posted
Sepracor losses grow but market keeps faith
Article | 22 February 1999
Sepracor posted revenues of $17.4 million for 1998, an increase of 13.7%compared with the previous year, though net loss deepened significantly to $93.4 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
